Ignite Creation Date:
2024-10-25 @ 7:52 PM
Last Modification Date:
2024-10-26 @ 3:40 PM
Study NCT ID:
NCT06593054
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
None
First Post:
2024-07-22
Brief Title:
To Learn How Different Forms of Study Medicine Are Taken up Into the Blood and the Effect of Food on Study Medicine in Healthy Adults
Sponsor:
None
Organization:
None
Study Overview
Official Title:
An Interventional Open-Label Single-Dose 4-Treatment 4-Period Crossover Study to Evaluate the Relative Bioavailability of CTB and AVI Administered Via Various Tablets or Capsule Formulations of PF-07612577 PF-06264006 CTB - PF-07338233 AVP and the Effect of Food on the Bioavailability of CTB and AVI Administered Via Tablets in Healthy Adult Participants
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to learn about the study medicine CTB-AVP for the treatment of severe urinary tract infections that require hospitalization
This study is seeking for
adult male and female participants who are healthy and weigh more than 50 kg
participants who have normal blood pressure normal kidney and liver function
participants willing to stay away from caffeine and other medicines for the duration of the study
Participants will be required to stay in the study clinic for two weeks All participants in this study will receive study medicine CTB-AVP by mouth one time each day on four different days Study medicine will be given in capsules or tablets on an empty stomach or will be taken with a meal The study will look at the experiences of people receiving the study medicine This will help determine if the study medicine is safe and effective
This study is seeking for
adult male and female participants who are healthy and weigh more than 50 kg
participants who have normal blood pressure normal kidney and liver function
participants willing to stay away from caffeine and other medicines for the duration of the study
Participants will be required to stay in the study clinic for two weeks All participants in this study will receive study medicine CTB-AVP by mouth one time each day on four different days Study medicine will be given in capsules or tablets on an empty stomach or will be taken with a meal The study will look at the experiences of people receiving the study medicine This will help determine if the study medicine is safe and effective
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None